default author photo

Saphire Lab/Xiaoying Yu

La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research

United States

  • La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research

SCHOLARLY PAPERS

2

DOWNLOADS

98

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Asymmetric and Non-Stoichiometric Recognition Results in Broad Protection Against Ebolaviruses by a Two-Antibody Cocktail

Number of pages: 58 Posted: 03 Jun 2021
Jacob C. Milligan, Carl W. Davis, Saphire Lab/Xiaoying Yu, Philipp A. Ilinykh, Kai Huang, Peter Halfmann, Robert W. Cross, Viktoriya Borisevich, Krystle N. Agans, Joan B. Geisbert, Chakravarthy Chennareddy, Arthur J. Goff, Ashley E. Piper, Sean Hui, Kelly Shaffer, Tierra Buck, Megan L. Heinrich, Luis M. Branco, Ian Crozier, Michael R. Holbrook, Jens H. Kuhn, Yoshihiro Kawaoka, Pamela J. Glass, Alexander Bukreyev, Thomas W. Geisbert, Gabriella Worwa, Rafi Ahmed and Erica Ollmann Saphire
La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, Emory University - Department of Microbiology and Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, University of Texas Medical Branch-Galveston - Department of Microbiology and Immunology, University of Texas Medical Branch-Galveston - Department of Pathology, University of Wisconsin - Madison - Influenza Research Institute, University of Texas Medical Branch-Galveston - Department of Microbiology and Immunology, University of Texas Medical Branch-Galveston - Department of Microbiology and Immunology, University of Texas Medical Branch-Galveston - Department of Microbiology and Immunology, University of Texas Medical Branch-Galveston - Department of Microbiology and Immunology, Emory University - Department of Microbiology and Immunology, U.S. Army Research Institute for Infectious Disease - Virology Division, U.S. Army Research Institute for Infectious Disease - Virology Division, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, Zalgen Labs, Zalgen Labs, Frederick National Laboratory for Cancer Research - Clinical Monitoring Research Program Directorate, Government of the United States of America - Integrated Research Facility at Fort Detrick, Government of the United States of America - Integrated Research Facility at Fort Detrick, University of Wisconsin-Madison - Influenza Research Institute, U.S. Army Research Institute for Infectious Disease - Virology Division, University of Texas Medical Branch-Galveston - Department of Pathology, University of Texas Medical Branch-Galveston - Galveston National Laboratory, Government of the United States of America - Integrated Research Facility at Fort Detrick, Emory University - Department of Microbiology and Immunology and La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research
Downloads 54 (1,020,567)

Abstract:

Loading...

2.

Potent, Omicron-Neutralizing Antibodies Isolated From a Patient Vaccinated 6 Months Before Omicron Emergence

Number of pages: 75 Posted: 20 Jan 2023
Kathryn Hastie, Saphire Lab/Xiaoying Yu, Fernanda Ana Sosa Batiz, Dawid Zyla, Stephanie S. Harkins, Chitra Hariharan, Hal Wasserman, Michelle Zandonatti, Robyn Miller, Erin Maule, Kenneth Kim, Kristen Valentine, Sujan Shresta and Erica Ollmann Saphire
La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research and La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research
Downloads 44 (1,133,231)

Abstract:

Loading...

Antibody responses, antibody therapeutic, Monoclonal antibody, Neutralization antibody, SARS-CoV-2, coronavirus, Omicron, variants of concern, immune evasion, Spike, receptor binding domain, cryo-EM